Basiliximab Completed Phase 4 Trials for Disorder Related to Renal Transplantation Prevention

Indications	Status	Purpose	Phase
DBCOND0032141 (Disorder Related to Renal Transplantation)	Completed	Prevention	4

clinicaltrials.gov Identifier	Title	Drugs
NCT00724022	Phase IV Study to Evaluate Calcineurin Inhibitor Reduced, Steroid Free Immunosuppression After Renal Transplantation	Antithymocyte immunoglobulin (rabbit) (DB00098) Basiliximab (DB00074) Mycophenolate mofetil (DB00688) Prednisolone (DB00860) Tacrolimus (DB00864)